Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial

Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial

Drug-eluting stents (DES) are the recommended stents for primary percutaneous coronary intervention (PCI). This study aimed to determine why interventional cardiologists used non-DES and how it influenced patient prognoses. The efficacy and safety outcomes of the different stents were also compared...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ota Hlinomaz, Zuzana Motovska, Jiri Knot, Roman Miklik, Mahmoud Sabbah, Milan Hromadka, Ivo Varvarovsky, Jaroslav Dusek, Michal Svoboda, Frantisek Tousek, Bohumil Majtan, Stanislav Simek, Marian Branny, Jiří Jarkovský
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
acute myocardial infarction
primary angioplasty
drug-eluting stent
bare-metal stent
bioresorbable scaffolds
ticagrelor
Medicine
R
Accès en ligne:https://doaj.org/article/4e7652a35f734b819b5d5aa732a9c607
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/4e7652a35f734b819b5d5aa732a9c607

Documents similaires